1979
DOI: 10.1136/jcp.32.6.584
|View full text |Cite
|
Sign up to set email alerts
|

Automated determination of red cell methaemoglobin reductase activity by a continuous-flow system for screening hereditary methaemoglobinaemia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

1980
1980
2014
2014

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 14 publications
0
3
0
Order By: Relevance
“…Experiments that use whole blood with intact erythrocytes are needed to determine the physiological relevance of either of these processes to rates of methemoglobin reduction. However, reported cytb 5 r activities are most commonly measured indirectly by spectrophotometric measurement of the enzyme's reduction of ferrocyanide-methemoglobin complex or NADH-ferricyanide in hemolysates as alternative substrates for methemoglobin (3,42). Alternatively, cytb 5 r activities have been studied in whole blood, but with the use of dilute suspensions of red blood cells washed after pharmacological induction of methemoglobinemia with hemoglobin-oxidizing agents (2,40).…”
mentioning
confidence: 99%
“…Experiments that use whole blood with intact erythrocytes are needed to determine the physiological relevance of either of these processes to rates of methemoglobin reduction. However, reported cytb 5 r activities are most commonly measured indirectly by spectrophotometric measurement of the enzyme's reduction of ferrocyanide-methemoglobin complex or NADH-ferricyanide in hemolysates as alternative substrates for methemoglobin (3,42). Alternatively, cytb 5 r activities have been studied in whole blood, but with the use of dilute suspensions of red blood cells washed after pharmacological induction of methemoglobinemia with hemoglobin-oxidizing agents (2,40).…”
mentioning
confidence: 99%
“…This condition is caused by deficiencies in the cytochrome b5 reductase enzyme, with two distinct, previously described forms of methemoglobinemia (I and II) 7,11,13,15 . Type I is a benign form caused by a deficiency in the soluble erythrocyte form of the enzyme, typically due to amino acid substitutions that result in protein instability.…”
Section: Discussionmentioning
confidence: 99%
“…A soluble form of these proteins in the erythrocytes is responsible for reducing MetHb back into functional hemoglobin. Several studies have demonstrated that methemoglobinemia is associated with genetic variations in both CYB5A and CYB5R3 , resulting in decreased enzyme activity 7,1115 .…”
Section: Introductionmentioning
confidence: 99%